{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:18:57Z","timestamp":1791407937487,"version":"4.3.3"},"reference-count":144,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03620"],"award-info":[{"award-number":["19H03620"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K08158"],"award-info":[{"award-number":["20K08158"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H05355"],"award-info":[{"award-number":["16H05355"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K10112"],"award-info":[{"award-number":["17K10112"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22591161"],"award-info":[{"award-number":["22591161"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K21189"],"award-info":[{"award-number":["15K21189"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaci.2021.05.018","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:24:36Z","timestamp":1624519476000},"page":"252-261.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-\u03b3"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8272-9588","authenticated-orcid":false,"given":"Miyuki","family":"Tsumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuka","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Tamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.05.018_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau8714","article-title":"Tuberculosis and impaired IL-23-dependent IFN-\u03b3 immunity in humans homozygous for a common TYK2 missense variant","volume":"3","author":"Boisson-Dupuis","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41590-018-0178-z","article-title":"Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency","volume":"19","author":"Kong","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6759","article-title":"Human IFN-\u03b3 immunity to mycobacteria is governed by both IL-12 and IL-23","volume":"3","author":"Mart\u00ednez-Barricarte","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imcb.12210","article-title":"Mendelian susceptibility to mycobacterial disease: 2014-2018 update","volume":"97","author":"Rosain","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2021.05.018_bib7","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-\u03b3 immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.05.018_bib8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib10","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1172\/JCI119810","article-title":"Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis","volume":"100","author":"Jouanguy","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.05.018_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.280.5368.1432","article-title":"Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency","volume":"280","author":"Altare","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.05.018_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.280.5368.1435","article-title":"Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients","volume":"280","author":"de Jong","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.05.018_bib13","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1172\/JCI4950","article-title":"Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection","volume":"102","author":"Altare","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.05.018_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.05.018_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ni.1992","article-title":"Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease","volume":"12","author":"Bustamante","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1084\/jem.20060085","article-title":"X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production","volume":"203","author":"Filipe-Santos","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1100066","article-title":"IRF8 mutations and human dendritic-cell immunodeficiency","volume":"365","author":"Hambleton","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/ng1581","article-title":"Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations","volume":"37","author":"Vogt","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib19","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.05.018_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10875-015-0173-1","article-title":"Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India","volume":"35","author":"Sharma","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fped.2017.00075","article-title":"Multifocal recurrent osteomyelitis and hemophagocytic lymphohistiocytosis in a boy with partial dominant IFN-\u03b3R1 deficiency: case report and review of the literature","volume":"5","author":"Staines-Boone","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib22","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3324\/haematol.2013.083741","article-title":"Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis","volume":"98","author":"Hirata","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2021.05.018_bib23","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","article-title":"Revisiting human IL-12R\u03b21 deficiency: a survey of 141 patients from 30 countries","volume":"89","author":"de Beaucoudrey","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.05.018_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MD.0b013e31828a01f9","article-title":"Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds","volume":"92","author":"Prando","year":"2013","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.05.018_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.05.018_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/jir.2011.0019","article-title":"Molecular mechanisms of the biphasic effects of interferon-gamma on osteoclastogenesis","volume":"32","author":"Cheng","year":"2012","journal-title":"J Interferon Cytokine Res"},{"issue":"suppl\u00a03","key":"10.1016\/j.jaci.2021.05.018_bib28","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","article-title":"Signaling crosstalk between RANKL and interferons in osteoclast differentiation","volume":"4","author":"Takayanagi","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.jaci.2021.05.018_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jbspin.2015.07.010","article-title":"The roles of interferons in osteoclasts and osteoclastogenesis","volume":"83","author":"Xiong","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaci.2021.05.018_bib30","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jmg.2007.049635","article-title":"The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction","volume":"44","author":"Okada","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.0513250","article-title":"Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis","volume":"95","author":"Mizoguchi","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2021.05.018_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.09.035","article-title":"Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants","volume":"140","author":"Kagawa","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1006\/bbrc.1999.2042","article-title":"CFU-GM-derived cells form osteoclasts at a very high efficiency","volume":"267","author":"Menaa","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2021.05.018_bib35","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.0802091","article-title":"IL-27 abrogates receptor activator of NF-kappa B ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos","volume":"183","author":"Furukawa","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.05.018_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol Cells"},{"key":"10.1016\/j.jaci.2021.05.018_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.biocel.2009.12.018","article-title":"NFATc1: functions in osteoclasts","volume":"42","author":"Zhao","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaci.2021.05.018_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.11005\/jbm.2014.21.4.233","article-title":"Regulation of NFATc1 in osteoclast differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"J Bone Metab"},{"key":"10.1016\/j.jaci.2021.05.018_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.jaci.2021.05.018_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1073\/pnas.97.1.91","article-title":"IFN consensus sequence binding protein potentiates STAT1-dependent activation of IFNgamma-responsive promoters in macrophages","volume":"97","author":"Contursi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2021.05.018_bib42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06217.x","article-title":"Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8","volume":"1237","author":"Ivashkiv","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2021.05.018_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/107999002753452755","article-title":"ICSBP\/IRF-8: its regulatory roles in the development of myeloid cells","volume":"22","author":"Tamura","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.jaci.2021.05.018_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cytogfr.2020.03.003","article-title":"Interferon regulatory factor 8 governs myeloid cell development","volume":"55","author":"Xia","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2021.05.018_bib45","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/nm.2007","article-title":"Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis","volume":"15","author":"Zhao","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib46","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.4049\/jimmunol.0900072","article-title":"Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors","volume":"183","author":"Ji","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib47","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2021.05.018_bib48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2017.02.012","article-title":"Interferon-\u03b3 released by activated CD8(+) T lymphocytes impairs the calcium resorption potential of osteoclasts in calcified human aortic valves","volume":"187","author":"Nagy","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2021.05.018_bib49","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.celrep.2016.08.051","article-title":"IFN-\u03b3 induces histone 3 lysine 27 trimethylation in a small subset of promoters to stably silence gene expression in human macrophages","volume":"16","author":"Qiao","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2021.05.018_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/ar3379","article-title":"Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors","volume":"13","author":"Zhao","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2021.05.018_bib51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jbmr.3690","article-title":"Inactivating mutation in IRF8 promotes osteoclast transcriptional programs and increases susceptibility to tooth root resorption","volume":"34","author":"Thumbigere-Math","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jaci.2021.05.018_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib53","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3899\/jrheum.160256","article-title":"Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies","volume":"43","author":"Hofmann","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2021.05.018_bib54","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","article-title":"Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment","volume":"15","author":"Hofmann","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jaci.2021.05.018_bib55","first-page":"1007","article-title":"Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells","volume":"29","author":"Abe","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z","article-title":"Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection","volume":"181","author":"Emile","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2021.05.018_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00281-015-0552-y","article-title":"A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections","volume":"38","author":"Wu","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaci.2021.05.018_bib58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0039-1700803","article-title":"Disseminated mycobacterium avium infection in a child with complete interferon-\u03b3 receptor 1 deficiency due to compound heterozygosis of IFNGR1 for a subpolymorphic copy number variation and a novel splice-site variant","volume":"9","author":"Bossi","year":"2020","journal-title":"J Pediatr Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10875-017-0430-6","article-title":"Long-term survival after hematopoietic stem cell transplantation for complete STAT1 deficiency","volume":"37","author":"Naviglio","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib61","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJM199612263352604","article-title":"Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Gu\u00e9rin infection","volume":"335","author":"Jouanguy","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10875-015-0173-1","article-title":"Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India","volume":"35","author":"Sharma","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10875-018-0548-1","article-title":"Impaired IL-12- and IL-23-mediated immunity due to IL-12Rbeta1 deficiency in Iranian patients with Mendelian susceptibility to mycobacterial disease","volume":"38","author":"Nekooie-Marnany","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10875-013-9882-5","article-title":"Interferon alpha treatment of patients with impaired interferon gamma signaling","volume":"33","author":"Bax","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.29262\/ram.v64i4.329","article-title":"[Disseminated infection by M. tuberculosis complex in patient with IFN-\u03b3 receptor 1 complete deficiency]","volume":"64","author":"Mart\u00ednez-Morales","year":"2017","journal-title":"Rev Alerg Mex"},{"key":"10.1016\/j.jaci.2021.05.018_bib66","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib67","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1182\/blood-2002-02-0433","article-title":"Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation","volume":"100","author":"Reuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.05.018_bib68","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-3476(99)70064-8","article-title":"Viral infections in interferon-gamma receptor deficiency","volume":"135","author":"Dorman","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.inf.0000060181.71042.b5","article-title":"Disseminated Mycobacterium peregrinum infection in a child with complete interferon-gamma receptor-1 deficiency","volume":"22","author":"Koscielniak","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2021.05.018_bib70","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10875-008-9253-9","article-title":"Chinese patients with defective IL-12\/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele","volume":"29","author":"Lee","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib71","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/j.ijid.2009.03.025","article-title":"Disseminated Mycobacterium scrofulaceum infection in a child with interferon-gamma receptor 1 deficiency","volume":"14","author":"Marazzi","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib72","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-007-9097-8","article-title":"Two patients with complete defects in interferon gamma receptor-dependent signaling","volume":"27","author":"Noordzij","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib73","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0301-472X(99)00077-6","article-title":"Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options","volume":"27","author":"Roesler","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2021.05.018_bib74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10875-019-00621-8","article-title":"Interferon-\u03b3 receptor 1 deficiency corrected by umbilical cord blood transplantation","volume":"39","author":"Michniacki","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib75","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10875-019-00672-x","article-title":"Current status of the management of Mendelian susceptibility to mycobacterial disease in mainland China","volume":"39","author":"Ying","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631298","article-title":"Clinical and molecular findings in Mendelian susceptibility to mycobacterial diseases: experience from India","volume":"12","author":"Taur","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib77","article-title":"Eight years of follow-up experience in children with mendelian susceptibility to mycobacterial disease and review of the literature","author":"Azarsiz","year":"2021","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CDLI.8.1.133-137.2001","article-title":"A point mutation in a domain of gamma interferon receptor 1 provokes severe immunodeficiency","volume":"8","author":"Allende","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib79","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/hmg\/ddp507","article-title":"A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon","volume":"19","author":"Kong","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000088682","article-title":"Disseminated Mycobacterium avium infection in a 20-year-old female\u00a0with partial recessive IFNgammaR1 deficiency","volume":"73","author":"Remiszewski","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.jaci.2021.05.018_bib81","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/hmg\/ddr029","article-title":"Partial recessive IFN-gammaR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds","volume":"20","author":"Sologuren","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8836685","article-title":"Mendelian susceptibility to mycobacterial disease: the first case of a diagnosed adult patient in the Czech Republic","volume":"2020","author":"Prucha","year":"2020","journal-title":"Case Reports Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib83","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.05.018_bib84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jmg.2007.049635","article-title":"The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-gamma receptor 1 and has a dominant-negative effect on interferon-gamma signal transduction","volume":"44","author":"Okada","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib85","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/432120","article-title":"Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency","volume":"41","author":"Zerbe","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib86","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/605532","article-title":"Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency","volume":"49","author":"Vinh","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/INF.0b013e3181f6f78a","article-title":"Meningoencephalitis caused by varicella-zoster virus reactivation in a child with dominant partial interferon-gamma receptor-1 deficiency","volume":"30","author":"Roesler","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaci.2021.05.018_bib88","first-page":"387","article-title":"[Interferon-gamma receptor 1 deficiency in a 19-month-old child: case report and literature review]","volume":"52","author":"Wang","year":"2014","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.jaci.2021.05.018_bib89","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/7701","article-title":"A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection","volume":"21","author":"Jouanguy","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0300-2977(01)00152-8","article-title":"Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor","volume":"59","author":"Arend","year":"2001","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/000992289403301007","article-title":"Multifocal M. intracellulare osteomyelitis in an immunocompetent child","volume":"33","author":"Raszka","year":"1994","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaci.2021.05.018_bib92","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.1542\/peds.107.4.e47","article-title":"Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation","volume":"107","author":"Villella","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2021.05.018_bib93","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1086\/339011","article-title":"Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type","volume":"185","author":"Sasaki","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib94","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10875-010-9498-y","article-title":"Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan","volume":"31","author":"Hoshina","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib95","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10156-012-0493-5","article-title":"Two cases of partial dominant interferon-gamma receptor 1 deficiency that presented with different clinical courses of bacille Calmette-Guerin multiple osteomyelitis","volume":"19","author":"Obinata","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jaci.2021.05.018_bib96","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaci.2013.07.054","article-title":"A novel mutation in IFN-gamma receptor 1 presenting as multisystem Mycobacterium intracellulare infection","volume":"133","author":"Rose","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-3083.2006.01775.x","article-title":"Novel mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infections","volume":"64","author":"Storgaard","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib98","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/525855","article-title":"Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency","volume":"46","author":"Glosli","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib99","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1086\/423804","article-title":"Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-gamma receptor mutation","volume":"39","author":"Han","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clim.2014.01.004","article-title":"Augmentation of antitubercular therapy with IFNgamma in a patient with dominant partial IFNgamma receptor 1 deficiency","volume":"151","author":"Takeda","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib101","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.4049\/jimmunol.169.7.3900","article-title":"Divergent role for TNF-alpha in IFN-gamma-induced killing of Toxoplasma gondii and Salmonella typhimurium contributes to selective susceptibility of patients with partial IFN-gamma receptor 1 deficiency","volume":"169","author":"Janssen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib102","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcped.2006.11.023","article-title":"[Multifocal infection due to Mycobacterium intracellulare: first case of interferon gamma receptor partial dominant deficiency in tropical French territory]","volume":"14","author":"Muszlak","year":"2007","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib103","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1067\/mpd.2001.117068","article-title":"Interferon-gamma receptor deficiency mimicking Langerhans' cell histiocytosis","volume":"139","author":"Edgar","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fped.2017.00075","article-title":"Multifocal recurrent osteomyelitis and hemophagocytic lymphohistiocytosis in a boy with partial dominant IFN-\u03b3R1 deficiency: case report and review of the literature","volume":"5","author":"Staines-Boone","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s10875-018-0509-8","article-title":"Autosomal dominant IFN-gammaR1 deficiency presenting with both atypical mycobacteriosis and tuberculosis in a BCG-vaccinated South African patient","volume":"38","author":"Glanzmann","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib106","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/ped.13691","article-title":"Multiple osteolytic lesions on the skull of a girl with Mendelian susceptibility to mycobacterial disease","volume":"60","author":"Shoji","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaci.2021.05.018_bib107","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s10875-020-00813-7","article-title":"Mendelian susceptibility to mycobacterial disease (MSMD): clinical and genetic features of 32 Iranian patients","volume":"40","author":"Mahdaviani","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10875-019-00720-6","article-title":"Mutual alteration of NOD2-associated Blau syndrome and IFN\u03b3R1 deficiency","volume":"40","author":"Parackova","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib109","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fimmu.2020.01161","article-title":"Transient decrease of circulating and tissular dendritic cells in patients with mycobacterial disease and with partial dominant IFNgammaR1 deficiency","volume":"11","author":"Dotta","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib111","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in\u00a0vitro but immunity to some low virulence viruses in\u00a0vivo","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib112","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10875-017-0430-6","article-title":"Long-term survival after hematopoietic stem cell transplantation for complete STAT1 deficiency","volume":"37","author":"Naviglio","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib113","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-\u03b3 and IFN-\u03b1 responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.05.018_bib114","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaip.2016.02.015","article-title":"A novel presentation of homozygous loss-of-function STAT-1 mutation in an infant with hyperinflammation: a case report and review of the literature","volume":"4","author":"Burns","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.05.018_bib115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/intimm\/dxaa043","article-title":"Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations","volume":"32","author":"Sakata","year":"2020","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib116","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jaip.2020.06.034","article-title":"A novel complete autosomal-recessive STAT1 LOF variant causes immunodeficiency with hemophagocytic lymphohistiocytosis-like hyperinflammation","volume":"8","author":"Boehmer","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.05.018_bib117","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.05.018_bib118","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","article-title":"A novel form of human STAT1 deficiency impairing early but not late responses to interferons","volume":"116","author":"Kong","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.05.018_bib119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-010-9480-8","article-title":"Novel STAT1 alleles in a patient with impaired resistance to mycobacteria","volume":"31","author":"Kristensen","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.05.018_bib121","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3324\/haematol.2013.083741","article-title":"Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis","volume":"98","author":"Hirata","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2021.05.018_bib122","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib123","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/humu.22113","article-title":"Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease","volume":"33","author":"Tsumura","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2021.05.018_bib124","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10875-012-9659-2","article-title":"A novel STAT1 mutation associated with disseminated mycobacterial disease","volume":"32","author":"Sampaio","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib125","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.09.035","article-title":"Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants","volume":"140","author":"Kagawa","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib126","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2016.11.004","article-title":"A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases","volume":"174","author":"Ueki","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib127","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20151750","article-title":"IL-12 drives functional plasticity of human group 2 innate lymphoid cells","volume":"213","author":"Lim","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.05.018_bib128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10875-018-0527-6","article-title":"A variety of Alu-mediated copy number variations can underlie IL-12R\u03b21 deficiency","volume":"38","author":"Rosain","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00251-017-1041-3","article-title":"Susceptibility to mycobacterial disease due to mutations in IL-12R\u03b21 in three Iranian patients","volume":"70","author":"Alinejad Dizaj","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaci.2021.05.018_bib130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12253","article-title":"Molecular analysis for patients with IL-12 receptor \u03b21 deficiency","volume":"86","author":"Ramirez-Alejo","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.jaci.2021.05.018_bib131","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10875-016-0292-3","article-title":"Hemophagocytic lymphohistiocytosis as a complication in patients with MSMD","volume":"36","author":"Muriel-Vizcaino","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib132","doi-asserted-by":"crossref","first-page":"356","DOI":"10.24953\/turkjped.2016.04.002","article-title":"Clinical and genetic features of IL12Rb1 deficiency: single center experience of 18 patients","volume":"58","author":"Tan","year":"2016","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib133","doi-asserted-by":"crossref","first-page":"331","DOI":"10.24953\/turkjped.2016.03.019","article-title":"Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene","volume":"58","author":"G\u00f6kt\u00fcrk","year":"2016","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib134","first-page":"370","article-title":"Mendelian susceptibility to mycobacterial disease due to IL-12R\u03b21 deficiency in three Iranian children","volume":"45","author":"Sarrafzadeh","year":"2016","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.jaci.2021.05.018_bib135","first-page":"161","article-title":"IL12R\u03b21 defect presenting with massive intra-abdominal lymphadenopathy due to Mycobacterium intracellulare infection","volume":"35","author":"Kadayifci","year":"2017","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib136","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10875-017-0435-1","article-title":"Severe enteropathy and hypogammaglobulinemia complicating refractory Mycobacterium tuberculosis complex disseminated disease in a child with IL-12R\u03b21 deficiency","volume":"37","author":"Arias","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib137","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fmicb.2017.00616","article-title":"Microbial disease spectrum linked to a novel IL-12R\u03b21 N-terminal signal peptide stop-gain homozygous mutation with paradoxical receptor cell-surface expression","volume":"8","author":"Louvain de Souza","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaci.2021.05.018_bib138","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s10875-018-0535-6","article-title":"Severe BCG-osis misdiagnosed as multidrug-resistant tuberculosis in an IL-12R\u03b21-deficient Peruvian girl","volume":"38","author":"Esteve-Sole","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib139","article-title":"IL-12R\u03b21 deficiency corresponding to concurrency of two diseases, mendelian susceptibility to mycobacterial disease and Crohn's disease","volume":"17","author":"Khoshnevisan","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.jaci.2021.05.018_bib140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.24953\/turkjped.2019.02.004","article-title":"Clinical findings and genetic analysis of the patients with IL-12R\u03b21 deficiency from southeast Turkey","volume":"61","author":"Do\u011fruel","year":"2019","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.jaci.2021.05.018_bib141","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2019.00058","article-title":"A Syrian refugee in Iraq diagnosed as a case of IL12RB1 deficiency in Japan using dried blood spots","volume":"10","author":"Al-Kzayer","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.05.018_bib142","article-title":"Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.05.018_bib143","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12026-019-09094-8","article-title":"Novel nonsense IL-12R\u03b21 mutation associated with recurrent tuberculosis","volume":"67","author":"Ul Akbar","year":"2019","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaci.2021.05.018_bib144","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10875-019-0593-4","article-title":"Molecular, immunological, and clinical features of 16 Iranian patients with Mendelian susceptibility to mycobacterial disease","volume":"39","author":"Sarrafzadeh","year":"2019","journal-title":"J Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492100823X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492100823X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:10:17Z","timestamp":1778627417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492100823X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S009167492100823X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.05.018","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-\u03b3","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}